Valuation Caplin Point Laboratories Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 03:30:48 16/06/2026 pm IST			5-day change	1st Jan Change
2,377.85 ^INR	+0.60%		+5.33%	+29.15%

15/05	Caplin Point Laboratories Limited, Q4 2026 Earnings Call, May 14, 2026
15/05	Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	30,571	51,529	45,291	1,00,038	1,52,221	1,79,665	-	-
Change	-	68.55%	-12.11%	120.88%	52.16%	18.03%	-	-
Enterprise Value (EV)	30,571	51,529	45,291	1,00,038	1,52,221	1,79,665	1,79,665	1,79,665
Change	-	68.55%	-12.11%	120.88%	52.16%	18.03%	0%	0%
P/E Ratio	12.7x	17.3x	12.1x	22x	28.5x	17.9x	25.2x	22.1x
PBR	2.58x	3.47x	2.41x	4.32x	5.34x	3.19x	4.08x	3.71x
PEG	-	0.7x	0.5x	1x	1.6x	0.9x	1.6x	1.6x
Capitalization / Revenue	2.88x	4.06x	3.09x	5.91x	7.86x	5.23x	7.22x	6.4x
EV / Revenue	0x	0x	0x	0x	0x	8.44x	7.22x	6.4x
EV / EBITDA	0x	0x	0x	0x	0x	24.2x	20.9x	18.3x
EV / EBIT	0x	0x	0x	-	0x	23.1x	19.3x	16.7x
EV / FCF	0x	0x	0x	0x	0x	47.3x	32.7x	33.2x
FCF Yield	6.39%	4.77%	1.72%	1.73%	1.58%	2.4%	3.06%	3.01%
Dividend per Share ²	3	2	2	2.5	3	-	4	4
Rate of return	0.74%	0.29%	0.34%	0.19%	0.15%	-	0.17%	0.17%
EPS ²	31.71	39.26	49.18	59.9	70.25	84.11	93.8	107
Distribution rate	9.46%	5.09%	4.07%	4.17%	4.27%	-	4.26%	3.74%
Net sales ¹	10,613	12,694	14,667	16,941	19,375	21,872	24,880	28,053
EBITDA ¹	3,286	3,947	4,411	5,514	6,469	7,609	8,604	9,810
EBIT ¹	3,152	3,478	4,520	-	5,810	8,036	9,321	10,752
Net income ¹	2,423	2,998	3,763	4,571	5,363	6,412	7,128	8,124
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	404.15	679.90	596.70	1,317.30	2,002.60	2,363.65	2,363.65	2,363.65
Nbr of stocks (in thousands)	75,643	75,789	75,903	75,942	76,012	76,012	-	-
Announcement Date	06/05/21	12/05/22	27/05/23	16/05/24	15/05/25	14/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CAPLIN POINT LABORATORIES LIMITED	29.14x	-	-	-	190.11Cr
SUN PHARMACEUTICAL INDUSTRIES LTD.	37.25x	7.05x	24.05x	0.83%	4.59TCr
OTSUKA HOLDINGS CO., LTD.	17.06x	1.9x	9x	1.42%	3.36TCr
CIPLA LIMITED	26.66x	3.27x	16.77x	0.9%	1.18TCr
ZYDUS LIFESCIENCES LIMITED	23.86x	4.17x	15.52x	0.75%	1.16TCr
KRKA, D. D.	19.79x	3.43x	12.41x	3.44%	928.06Cr
GEDEON RICHTER	8.47x	1.99x	5.22x	5.12%	732.74Cr
ONO PHARMACEUTICAL CO., LTD.	14.93x	1.96x	7.43x	3.59%	664.6Cr
GLENMARK PHARMACEUTICALS LIMITED	32.74x	3.72x	15.82x	0.24%	643.96Cr
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	41.76x	-	-	-	515.89Cr
Average	25.17x	3.44x	13.28x	2.04%	1.4TCr
Weighted average by Cap.	26.50x	4.21x	15.75x	1.51%